| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.89B | 5.09B | 3.31B | 2.80B | 2.36B |
| Gross Profit | 3.85B | 2.61B | 1.72B | 1.06B | 1.00B |
| EBITDA | 982.04M | 886.05M | 858.22M | 291.38M | -337.03M |
| Net Income | 934.53M | 480.31M | 512.85M | 130.13M | -286.28M |
Balance Sheet | |||||
| Total Assets | 4.40B | 3.58B | 2.79B | 1.72B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 2.80B | 2.29B | 1.56B | 746.13M | 890.71M |
| Total Debt | 86.04M | 83.32M | 108.27M | 112.19M | 10.77M |
| Total Liabilities | 1.82B | 1.93B | 843.36M | 482.21M | 782.33M |
| Stockholders Equity | 2.44B | 1.54B | 1.12B | 707.82M | 476.80M |
Cash Flow | |||||
| Free Cash Flow | 1.40B | 1.05B | 743.56M | 301.74M | 389.85M |
| Operating Cash Flow | 1.42B | 1.06B | 753.50M | 312.64M | 393.85M |
| Investing Cash Flow | -570.62M | -86.77M | 214.58M | -356.56M | -55.10M |
| Financing Cash Flow | -304.67M | -318.59M | -162.34M | -139.59M | -29.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$12.21B | 27.92 | 41.82% | ― | 35.42% | 87.47% | |
64 Neutral | HK$3.64B | 24.36 | -8.12% | ― | 3.16% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$28.13B | 452.18 | 1.71% | ― | 12.11% | ― | |
56 Neutral | HK$5.96B | 45.10 | -159.21% | ― | 19.85% | ― | |
50 Neutral | HK$11.18B | 39.74 | 4.80% | ― | 81.43% | ― | |
42 Neutral | HK$5.70B | -27.23 | -66.11% | ― | 18.94% | 89.36% |